Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	179.11	95.05	34.06
Graham Fair Price	-47.98	21689.16	41691.98
PEG	331.08	-0.69	0.16
Price/Book	-3.07	0.49	0.50
Price/Cash Flow	146.04	33.45	13.59
Prices/Earnings	250.10	87.52	-25.00
Price/Sales	8.52	1.42	1.31
Price/FCF	146.04	33.45	13.59
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-10.85	0.11	0.13
Operating Margin	-31.80	0.03	0.04
ROA	-73.57	< 0.005	< 0.005
ROE	< 0.005	< 0.005	-72.31
ROIC	< 0.005	< 0.005	-11.50
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.09	-0.11	-19.92
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.04	-0.40	-793.61
EPS QOQ	-1.57	1.27	-18.79
FCF QOQ	3.43	-0.61	-82.18
Revenue QOQ	0.18	-0.12	-33.97
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	84.65	102.57	21.16
Days Sales Outstanding (DSO)	60.77	81.90	34.76
Inventory Turnover	1.06	0.88	-17.47
Debt/Capitalization	0.32	0.34	7.00
Quick Ratio	0.54	0.50	-7.70
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	123793.87	122392.49	-1.13
Cash	14588.82	8803.14	-39.66
Capex	-1010.08	-687.41	31.95
Free Cash Flow	4590.55	1788.01	-61.05
Revenue	47596.49	42031.54	-11.69
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.03	1.00	-3.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	16.28	48.38	197.18
Naive Interpretation	Member

06 - Financial Health · Bad

Rating